Raphael Pharmaceutical Inc. (RAPH): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$53.0K
As of 2025-12-31
$7.0K
As of 2026-06-30
$422.0K2020-12-31: $323.0K2021-12-31: $422.0K2022-12-31: $333.0K2023-12-31: $239.0K2024-12-31: $27.0K2025-12-31: $53.0K$53.0K
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$53.0K+96.3%2026-03-31, Balance as of period end
2024-12-31$27.0K-88.7%2026-03-31, Balance as of period end
2023-12-31$239.0Kn/c2025-03-31, Balance as of period end
2022-12-31$333.0K-21.1%2024-03-28, Balance as of period end
2021-12-31$422.0K+30.7%2023-05-25, Balance as of period end
2020-12-31$323.0Kn/a2022-03-30, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Raphael Pharmaceutical Inc. (RAPH)2025-12-31$53.0K+96.3%
China Foods Holdings Ltd. (CFOO)2025-12-31$212.9K-51.1%
Nutra Pharma Corp (NPHC)2025-12-31$584.6K-2.5%
Adia Nutrition, Inc. (ADIA)2025-12-31$594.8K-10.7%
Aibotics, Inc. (AIBT)2025-12-31$874.7K-40.0%
TFA Therapeutics, Inc. (RAJAF)2025-12-31$4.66M+0.7%
Regencell Bioscience Holdings Ltd (RGC)2025-06-30$5.76M-31.8%
Target Group Inc. (CBDY)2025-12-31$6.18M-18.4%
Functional Brands Inc. (MEHA)2025-12-31$9.11M+27.0%

Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗